| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 402 | 401.4 | 400.8 | 400 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 3,789.5 | 3,217.5 | 2,891.2 | 2,418.3 |
Net Worth | 4,191.5 | 3,618.9 | 3,292 | 2,818.3 |
Minority Interest | ||||
Debt | 332.4 | 638.6 | 1,021.6 | 892.9 |
Deferred Tax Liability Net | 128.5 | 122.1 | 125.2 | 99.8 |
Total Liabilities | 4,652.4 | 4,379.6 | 4,438.8 | 3,811 |
Fixed Assets | 3,077.5 | 2,386.1 | 2,739.2 | 2,438.2 |
Intangible Assets | ||||
Investments | 927.6 | 940.8 | 1,034.4 | 702.3 |
Deferred Tax Asset Net | 178.3 | 201.6 | 190.3 | 188.5 |
Networking Capital | -59.2 | 341.8 | -40.2 | -156.2 |
Inventories | 234 | 332.8 | 179.4 | 59.6 |
Inventory Days | 25.17 | 9.98 | ||
Sundry Debtors | 427.5 | 484.4 | 508.2 | 474.4 |
Debtor Days | 71.3 | 79.45 | ||
Other Current Assets | 589.3 | 1,115.1 | 519.4 | 476.1 |
Sundry Creditors | -310.2 | -304.2 | -344.9 | -328.3 |
Creditor Days | 48.39 | 54.98 | ||
Other Current Liabilities | -999.8 | -1,286.3 | -902.3 | -838 |
Cash | 528.2 | 509.3 | 515.1 | 638.2 |
Total Assets | 4,652.4 | 4,379.6 | 4,438.8 | 3,811 |
The purchase is anticipated to enhance Syngene's position in the biologics contract development and manufacturing organization (CDMO) arena, specifically in the US market.
The company reported an operating EBITDA of ₹343.60 Crore in the quarter four of FY25. It registered a growth of 8.4% on a year-on-year basis.
This acquisition will also augment Syngene’s biologics capabilities and further strengthen its global presence.
The company's revenue from operations also grew healthily, up by 10.6% YoY to ₹943 crore, as against ₹853.5 crore in Q3 FY24.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
